載入...
Analysis of FDA’s IQOS marketing authorisation and its policy impacts
BACKGROUND: Philip Morris Products SA (PMPSA) submitted a premarket tobacco application (PMTA) to US Food and Drug Administration (FDA) seeking an order permitting it to market IQOS in the USA. US law requires FDA to deny marketing authorisation if applicants fail to demonstrate that their product i...
Na minha lista:
| 發表在: | Tob Control |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7952009/ https://ncbi.nlm.nih.gov/pubmed/32601147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/tobaccocontrol-2019-055585 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|